168 related articles for article (PubMed ID: 24913813)
1. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
Mai C; Zhao JJ; Tang XF; Wang W; Pan K; Pan QZ; Zhang XF; Jiang SS; Zhao BW; Li YF; Xia JC; Zhou ZW
Med Oncol; 2014 Jul; 31(7):53. PubMed ID: 24913813
[TBL] [Abstract][Full Text] [Related]
2. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
3. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
Himmelfarb M; Klopocki E; Grube S; Staub E; Klaman I; Hinzmann B; Kristiansen G; Rosenthal A; Dürst M; Dahl E
Cancer Lett; 2004 Feb; 204(1):69-77. PubMed ID: 14744536
[TBL] [Abstract][Full Text] [Related]
4. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
Huth S; Heise R; Vetter-Kauczok CS; Skazik C; Marquardt Y; Czaja K; Knüchel R; Merk HF; Dahl E; Baron JM
Exp Dermatol; 2015 Sep; 24(9):663-8. PubMed ID: 25809190
[TBL] [Abstract][Full Text] [Related]
5. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.
Kloten V; Rose M; Kaspar S; von Stillfried S; Knüchel R; Dahl E
Epigenetics; 2014 Sep; 9(9):1290-301. PubMed ID: 25093535
[TBL] [Abstract][Full Text] [Related]
7. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
Veeck J; Breuer E; Rose M; Chorovicer M; Naami A; Bektas N; Alkaya S; von Serényi S; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():338-46. PubMed ID: 18810445
[TBL] [Abstract][Full Text] [Related]
8. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
Sasaki K; Kurahara H; Young ED; Natsugoe S; Ijichi A; Iwakuma T; Welch DR
Clin Exp Metastasis; 2017 Apr; 34(3-4):229-239. PubMed ID: 28289921
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Rose M; Gaisa NT; Antony P; Fiedler D; Heidenreich A; Otto W; Denzinger S; Bertz S; Hartmann A; Karl A; Knüchel R; Dahl E
Carcinogenesis; 2014 Mar; 35(3):727-36. PubMed ID: 24265292
[TBL] [Abstract][Full Text] [Related]
12. The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
Rose M; Noetzel E; Kistermann J; Eschenbruch J; Rushrush S; Gan L; Knüchel R; Gaisa NT; Dahl E
Cells; 2021 Apr; 10(5):. PubMed ID: 33924987
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia.
Oing C; Jost E; Dahl E; Wilop S; Brümmendorf TH; Galm O
Clin Epigenetics; 2011 Aug; 2(2):419-23. PubMed ID: 22704354
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.
Wang P; Mai C; Wei YL; Zhao JJ; Hu YM; Zeng ZL; Yang J; Lu WH; Xu RH; Huang P
Med Oncol; 2013 Jun; 30(2):552. PubMed ID: 23550275
[TBL] [Abstract][Full Text] [Related]
16. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
19. Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma.
Chen M; Ma J; Xie X; Su M; Zhao D
Cancer Sci; 2024 May; 115(5):1665-1679. PubMed ID: 38475675
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
